Literature DB >> 1987100

Lenses of diabetic patients "yellow" at an accelerated rate similar to older normals.

M Lutze1, G H Bresnick.   

Abstract

The authors used a psychophysical method to measure lens transmission of young, type I diabetic patients and normal controls. The results from normal controls agreed with previously published reports of decreasing lens transmission with age, and those from diabetic subjects suggested that lenses of young, type I diabetic patients age or "yellow" at an accelerated rate that was similar to that of normal controls over the age of 60 yr. The rate of accelerated lens density that occurs per year with the duration of diabetes is similar to the rate of accelerated lens density that occurs per year with patient age over 60 yr. A possible molecular explanation for the accelerated lens yellowing in both populations is discussed. Both diabetic individuals and the older normal populations have elevated plasma glucose levels and therefore may have accelerated glycosylation of lens proteins which causes increased lens yellowing.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1987100

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  20 in total

1.  Straylight, lens yellowing and aberrations of eyes in Type 1 diabetes.

Authors:  X Adnan; Marwan Suheimat; Ankit Mathur; Nathan Efron; David A Atchison
Journal:  Biomed Opt Express       Date:  2015-03-13       Impact factor: 3.732

2.  The Hermann-Hering grid illusion demonstrates disruption of lateral inhibition processing in diabetes mellitus.

Authors:  Nigel P Davies; Antony B Morland
Journal:  Br J Ophthalmol       Date:  2002-02       Impact factor: 4.638

3.  Simultaneous noninvasive clinical measurement of lens autofluorescence and rayleigh scattering using a fluorescence biomicroscope.

Authors:  John Burd; Stephen Lum; Frederick Cahn; Keith Ignotz
Journal:  J Diabetes Sci Technol       Date:  2012-11-01

4.  Risk factors associated with contrast sensitivity loss in diabetic patients.

Authors:  A A Dosso; E R Bonvin; Y Morel; A Golay; J P Assal; P M Leuenberger
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-05       Impact factor: 3.117

5.  Effect of diabetes associated increases in lens optical density on colour discrimination in insulin dependent diabetes.

Authors:  K J Hardy; J H Scarpello; D H Foster; J D Moreland
Journal:  Br J Ophthalmol       Date:  1994-10       Impact factor: 4.638

6.  Spatial visual filtering in diabetes mellitus.

Authors:  Nigel Philip Davies; Antony Bryan Morland
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-05-07       Impact factor: 3.117

7.  Lens fluorescence and metabolic control in type 1 diabetic patients: a 14 year follow up study.

Authors:  L Kessel; B Sander; P Dalgaard; M Larsen
Journal:  Br J Ophthalmol       Date:  2004-09       Impact factor: 4.638

8.  Extent of foveal tritanopia in diabetes mellitus.

Authors:  N Davies; A Morland
Journal:  Br J Ophthalmol       Date:  2003-06       Impact factor: 4.638

9.  Assessment of colour vision as a screening test for sight threatening diabetic retinopathy before loss of vision.

Authors:  G L Ong; L G Ripley; R S B Newsom; A G Casswell
Journal:  Br J Ophthalmol       Date:  2003-06       Impact factor: 4.638

10.  Effect of short term changes in blood glucose on visual pathway function in insulin dependent diabetes.

Authors:  K J Hardy; M O Scase; D H Foster; J H Scarpello
Journal:  Br J Ophthalmol       Date:  1995-01       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.